25 Hydroxy Vitamin D Level, Bone Health, Vitamin D and Calcium Intake in Chilean Patients with Phenylketonuria and Hyperphenylalaninemias

dc.coverageDOI: 10.1590/2326-4594-JIEMS-2021-0004
dc.creatorLeiva, C.
dc.creatorBravo, P.
dc.creatorArias, C.
dc.creatorCabello, J. F.
dc.creatorLeal-Witt, M. J.
dc.creatorSalazar, F.
dc.creatorCornejo, V.
dc.date2021
dc.date.accessioned2025-11-18T19:45:33Z
dc.date.available2025-11-18T19:45:33Z
dc.description<p>It has been shown that there is a decrease in the concentrations of 25 hydroxyvitamin D (25-OHD) and bone mineral density (BMD) in patients with phenylketonuria (PKU) in their follow-up. Our objective was to determine concentrations of 25-OHD in subjects with PKU and hyperphenylalaninemia (HPA). Transversal analytical study considered three groups: G1-PKU with neonatal diagnosis and formula intake without Phe; G2-HPA, without specific treatment and G3-C control group. Sixteen patients per group (aged 6-23) were included. Levels of 25-OHD, lumbar spine (L2-L4), femur and total BMD, intact parathormone (PTH) and vitamin D (VitD) and calcium intake were calculated. The Kruskal-Wallis statistical test was applied (p-value&lt;0,05). Significant differences were detected in concentrations of 25-OHD between G1-PKU and G2-HPA (38.9 ng/mL; 28 ng/mL, respectively) (NV: &gt;30 ng/mL). G1-PKU had a higher intake of VitD, with differences among groups. There were no significant differences among groups in relation to BMD and intact PTH. In conclusion, G1-PKU under treatment and with good adherence, does not present VitD deficiency and no BMD alterations are observed. In contrast, G2-HPA had a lower intake of VitD and decreased 25-OHD concentrations which could affect the bone architecture in the long term. Further studies on the G2-HPA are suggested.</p>eng
dc.identifierhttps://investigadores.uandes.cl/en/publications/bd999427-b141-4dc5-b872-6a18013d8bdc
dc.identifier.urihttps://repositorio.uandes.cl/handle/uandes/54028
dc.languageeng
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.9 (2021)
dc.subjectphenylketonuria
dc.subjectvitamin D and bone mineral density
dc.subjectSDG 3 - Good Health and Well-being
dc.title25 Hydroxy Vitamin D Level, Bone Health, Vitamin D and Calcium Intake in Chilean Patients with Phenylketonuria and Hyperphenylalaninemiaseng
dc.typeArticleeng
dc.typeArtículospa
Files
Collections